PHP
PODD icon

Parkman Healthcare Partners’s Insulet PODD Stock Holding History

Parkman Healthcare Partners’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Sell
131,378
-25,183
-16% -$4.2M 2.05% 17
2026
Q1 		$32.9M Buy
156,561
+15,701
+11% +$3.95M 3.39% 4
2025
Q4 		$40M Buy
140,860
+24,622
+21% +$7.7M 3.81% 2
2025
Q3 		$35.9M Buy
116,238
+10,476
+10% +$3.28M 3.74% 4
2025
Q2 		$33.2M Sell
105,762
-24,752
-19% -$7.14M 3.82% 2
2025
Q1 		$34.3M Buy
130,514
+4,753
+4% +$1.29M 4.07% 1
2024
Q4 		$32.8M Sell
125,761
-33,928
-21% -$8.54M 4.37% 3
2024
Q3 		$37.2M Sell
159,689
-19,616
-11% -$4.03M 4.74% 2
2024
Q2 		$36.2M Buy
179,305
+88,356
+97% +$15.9M 4.85% 2
2024
Q1 		$15.6M Buy
90,949
+2,274
+3% +$424K 1.91% 14
2023
Q4 		$19.2M Buy
88,675
+46,650
+111% +$8M 2.71% 9
2023
Q3 		$6.7M Sell
42,025
-16,026
-28% -$3.59M 1.23% 28
2023
Q2 		$16.7M Buy
58,051
+29,307
+102% +$8.9M 2.9% 7
2023
Q1 		$9.17M Buy
28,744
+10,702
+59% +$3.17M 1.99% 18
2022
Q4 		$5.31M Buy
18,042
+988
+6% +$272K 1.41% 24
2022
Q3 		$3.91M Buy
17,054
+3,165
+23% +$793K 1.11% 28
2022
Q2 		$3.03M Buy
13,889
+1,218
+10% +$277K 1.11% 31
2022
Q1 		$3.38M Sell
12,671
-4,329
-25% -$1.06M 0.99% 37
2021
Q4 		$4.52M Sell
17,000
-17,340
-50% -$5.03M 1% 31
2021
Q3 		$9.76M Sell
34,340
-1,000
-3% -$285K 2.47% 13
2021
Q2 		$9.7M Buy
35,340
+4,171
+13% +$1.13M 2.12% 14
2021
Q1 		$8.13M Buy
31,169
+582
+2% +$156K 1.89% 17
2020
Q4 		$7.82M Sell
30,587
-1,916
-6% -$475K 2% 17
2020
Q3 		$7.69M Buy
32,503
+15,003
+86% +$3.16M 2.04% 17
2020
Q2 		$3.4M Buy
+17,500
New +$3.35M 0.96% 37

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Parkman Healthcare Partners's PODD Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its Insulet (PODD) stake by 16% in Q2 2026, selling an estimated $4.2M and leaving 131,378 shares worth $20M. The position accounts for 2.05% of the portfolio, ranked #17.

Parkman Healthcare Partners first reported a position in PODD in Q2 2020 and has held it in 25 quarters since. The position peaked at $40M in Q4 2025. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Parkman Healthcare Partners held 131,378 shares of Insulet worth $20M as of Q2 2026.
  • Parkman Healthcare Partners sold 25,183 Insulet shares in Q2 2026, an estimated $4.2M.
  • Insulet made up 2.05% of Parkman Healthcare Partners's portfolio in Q2 2026, its #17 holding.
  • Parkman Healthcare Partners first reported a position in Insulet in Q2 2020 and has held it in 25 quarters since.
  • Parkman Healthcare Partners's Insulet position peaked at $40M in Q4 2025.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.